PECAM1 and atherosclerosis: A major fly in the ointment, however, is that large-scale inhibition of adhesion molecules or chemokines is often a double-edged sword, as several key players in leukocyte recruitment act differently in different tissues or have different, sometimes conflicting effects on atherosclerosis, as is the case with PECAM-1 (397).